SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.
Date Value
June 30, 2024 495.06M
March 31, 2024 475.59M
December 31, 2023 451.96M
September 30, 2023 422.69M
June 30, 2023 395.04M
March 31, 2023 359.11M
December 31, 2022 320.69M
September 30, 2022 284.62M
June 30, 2022 252.26M
March 31, 2022 224.27M
December 31, 2021 202.62M
September 30, 2021 182.47M
June 30, 2021 162.44M
March 31, 2021 140.73M
Date Value
December 31, 2020 127.87M
September 30, 2020 117.44M
June 30, 2020 106.66M
March 31, 2020 99.95M
December 31, 2019 90.46M
September 30, 2019 78.38M
June 30, 2019 69.41M
March 31, 2019 61.88M
December 31, 2018 53.53M
September 30, 2018 47.66M
June 30, 2018 42.37M
March 31, 2018 36.94M
December 31, 2017 32.36M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

90.46M
Minimum
Dec 2019
495.06M
Maximum
Jun 2024
258.52M
Average
224.27M
Median
Mar 2022

SG&A Expense (TTM) Benchmarks

Nevro Corp 326.85M
Axonics Inc 264.58M
Inari Medical Inc 406.98M
Electromed Inc 34.49M
Myomo Inc 20.12M